737 related articles for article (PubMed ID: 26963689)
1. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
[TBL] [Abstract][Full Text] [Related]
2. Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder.
Smagula SF; Wallace ML; Anderson SJ; Karp JF; Lenze EJ; Mulsant BH; Butters MA; Blumberger DM; Diniz BS; Lotrich FE; Dew MA; Reynolds CF
J Psychiatr Res; 2016 Oct; 81():112-8. PubMed ID: 27438687
[TBL] [Abstract][Full Text] [Related]
3. Impact of Prior Treatment on Remission of Late-Life Depression with Venlafaxine and Subsequent Aripiprazole or Placebo Augmentation.
Hsu JH; Mulsant BH; Lenze EJ; Karp JF; Lavretsky H; Roose SP; Reynolds CF; Blumberger DM
Am J Geriatr Psychiatry; 2016 Oct; 24(10):918-22. PubMed ID: 27538352
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.
Lenze EJ; Mulsant BH; Blumberger DM; Karp JF; Newcomer JW; Anderson SJ; Dew MA; Butters MA; Stack JA; Begley AE; Reynolds CF
Lancet; 2015 Dec; 386(10011):2404-12. PubMed ID: 26423182
[TBL] [Abstract][Full Text] [Related]
5. Specific depressive symptoms predict remission to aripiprazole augmentation in late-life treatment resistant depression.
Gebara MA; DiNapoli EA; Kasckow J; Karp JF; Blumberger DM; Lenze EJ; Mulsant BH; Reynolds CF
Int J Geriatr Psychiatry; 2018 Feb; 33(2):e330-e335. PubMed ID: 28975710
[TBL] [Abstract][Full Text] [Related]
6. Moderators of Remission in Patients With Late-Life Depression: Where Do We Go Next?
Taylor WD
JAMA Psychiatry; 2016 Apr; 73(4):319-20. PubMed ID: 26963364
[No Abstract] [Full Text] [Related]
7. Clinical Predictors of Extrapyramidal Symptoms Associated With Aripiprazole Augmentation for the Treatment of Late-Life Depression in a Randomized Controlled Trial.
Hsu JH; Mulsant BH; Lenze EJ; Sanches M; Karp JF; Reynolds CF; Blumberger DM
J Clin Psychiatry; 2018 Jun; 79(4):. PubMed ID: 29924506
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
Sheffrin M; Driscoll HC; Lenze EJ; Mulsant BH; Pollock BG; Miller MD; Butters MA; Dew MA; Reynolds CF
J Clin Psychiatry; 2009 Feb; 70(2):208-13. PubMed ID: 19210951
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
[TBL] [Abstract][Full Text] [Related]
11. Predicting Remission in Late-Life Major Depression: A Clinical Algorithm Based Upon Past Treatment History.
Buchalter ELF; Oughli HA; Lenze EJ; Dixon D; Miller JP; Blumberger DM; Karp JF; Reynolds CF; Mulsant BH
J Clin Psychiatry; 2019 Dec; 80(6):. PubMed ID: 31846575
[TBL] [Abstract][Full Text] [Related]
12. Association between lean muscle mass and treatment-resistant late-life depression in the IRL-GRey randomized controlled trial.
Ainsworth NJ; Brender R; Gotlieb N; Zhao H; Blumberger DM; Karp JF; Lenze EJ; Nicol GE; Reynolds CF; Wang W; Mulsant BH
Int Psychogeriatr; 2023 Dec; 35(12):707-716. PubMed ID: 36594430
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults.
Smagula SF; Butters MA; Anderson SJ; Lenze EJ; Dew MA; Mulsant BH; Lotrich FE; Aizenstein H; Reynolds CF
JAMA Psychiatry; 2015 Oct; 72(10):1021-8. PubMed ID: 26288246
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.
Berman RM; Marcus RN; Swanink R; McQuade RD; Carson WH; Corey-Lisle PK; Khan A
J Clin Psychiatry; 2007 Jun; 68(6):843-53. PubMed ID: 17592907
[TBL] [Abstract][Full Text] [Related]
15. General Predictors and Moderators of Depression Remission: A VAST-D Report.
Zisook S; Johnson GR; Tal I; Hicks P; Chen P; Davis L; Thase M; Zhao Y; Vertrees J; Mohamed S
Am J Psychiatry; 2019 May; 176(5):348-357. PubMed ID: 30947531
[TBL] [Abstract][Full Text] [Related]
16. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
Lam RW; Levitt AJ; Levitan RD; Michalak EE; Cheung AH; Morehouse R; Ramasubbu R; Yatham LN; Tam EM
JAMA Psychiatry; 2016 Jan; 73(1):56-63. PubMed ID: 26580307
[TBL] [Abstract][Full Text] [Related]
18. Depression Remission Rates Among Older Black and White Adults: Analyses From the IRL-GREY Trial.
Hall CA; Simon KM; Lenze EJ; Dew MA; Begley A; Butters MA; Blumberger DM; Stack JA; Mulsant B; Reynolds CF
Psychiatr Serv; 2015 Dec; 66(12):1303-11. PubMed ID: 26278231
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
Mischoulon D; Witte J; Levy M; Papakostas GI; Pet LR; Hsieh WH; Pencina MJ; Ward S; Pollack MH; Fava M
J Clin Psychiatry; 2012 Mar; 73(3):353-7. PubMed ID: 21939613
[TBL] [Abstract][Full Text] [Related]
20. Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: a pooled analysis.
Stewart TD; Hatch A; Largay K; Sheehan JJ; Marler SV; Berman RM; Nelson JC
J Affect Disord; 2014 Jun; 162():20-5. PubMed ID: 24766999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
